Additional conjugation methods and immunogenicity of Bacillus anthracis poly-γ-D-glutamic acid-protein conjugates

Infection and Immunity

Volumn 74, Issue 8, 2006, Pages 4744-4749

  Kubler Kielb, Joanna ^a   Liu, Teh Yung ^a   Mocca, Christopher ^a   Majadly, Fathy ^a   Robbins, John B ^a   Schneerson, Rachel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BOVINE SERUM ALBUMIN; CARRIER PROTEIN; GLUTAMIC ACID DERIVATIVE; HYDRAZONE DERIVATIVE; OXIME; POLY(GAMMA DEXTRO GLUTAMIC ACID); POLYPEPTIDE; PSEUDOMONAS EXOTOXIN; RECOMBINANT ANTIGEN; SULFIDE; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL MEMBRANE; COVALENT BOND; DRUG CONJUGATION; HOST RESISTANCE; IMMUNOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; FEMALE; IMMUNIZATION; MICE; POLYGLUTAMIC ACID; SULFIDES; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 33746634315     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00315-06     Document Type: Article

References (29)

1. Carlsson, J., H. Drevin, and R. Axen. 1978. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio) propionate, a new heterobifunctional reagent. Biochem. J. 173:723-737.
2. Centers for Disease Control and Prevention. 2001. Human anthrax associated with an epizootic among livestock-North Dakota, 2000. Morb. Mortal. Wkly. Rep. 50:677-680.
3. Chabot, D. J., A. Scorpio, S. A. Tobery, S. F. Little, S. L. Norris, and A. M. Friedlander. 2004. Anthrax capsule vaccine protects against experimental infection. Vaccine 23:43-47.
4. Dick, W. E., and M. Beurret, Jr. 1989. Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design and preparation factors. Contrib. Microbiol. Immunol. 10:48-114.
5. Dragon, D. C., R. P. Rennie, and B. T. Elkin. 2001. Detection of anthrax spores in endemic regions of northern Canada. J. Appl. Microbiol. 91:435-441.
6. Fields, R. 1971. The measurement of amino groups in proteins and peptides. Biochem. J. 124:581-590.
7. Goodman, J. W., and D. E. Nitecki. 1966. Immunochemical studies on the poly-gamma-D-glutamyl capsule of Bacillus anthracis. I. Characterization of the polypeptide and of the specificity of its reaction with rabbit antisera. Biochemistry 5:657-663.
8. Johansson, H. J., C. Jagersten, and J. Shiloach. 1996. Large scale recovery and purification of periplasmic recombinant protein from E. coli using expanded bed adsorption chromatography followed by new ion exchange media. J. Biotechnol. 48:9-14.
9. Kaya, A., M. A. Tasyaran, S. Erol, and Z. Ozkurt. 2002. Anthrax in adults and children: a review of 132 cases in Turkey. Eur. J. Clin. Microbiol. Infect. Dis. 21:258-261.
10. Kozel, T. R., W. J. Murphy, S. Brandt, B. R. Blazar, J. A. Lovchik, P. Thorkildson, A. Percival, and C. R. Lyons. 2004. mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc. Natl. Acad. Sci. USA 101:5042-5047.
11. Kubler-Kielb, J., and V. Pozsgay. 2005. Synthesis of neoglycoproteins by chemoselective ligation through an aminoxy-thiol heterbifunctional reagent. J. Org. Chem. 70:6987-6990.
12. Kumar, A., R. Kanugo, S. Bhattacharia, S. Badrinath, and R. P. Swaminathan. 2000. Human anthrax in India. J. Commun. Dis. 32:240-246.
13. Laferriere, C. A., R. K. Sood, J. M. de Muys, F. Michon, and H. J. Jennings. 1998. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes. Infect. Immun. 66:2441-2446.
14. Little, S. F., B. E. Ivins, P. F. Fellows, M. L. M. Pitt, S. L. W. Norris, and G. P. Andrews. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422-430.
15. Little, S. F., S. H. Leppla, and E. Cora. 1988. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect. Immun. 56:1807-1813.
16. Lowry, J. O., N. J. Rosenbrough, A. L. Fair, and R. Randall. 1951. Protein measurement with the Polin phenol reagent. J. Biol. Chem. 193:265-275.
17. Mawas, F., J. Niggemann, C. Jones, M. J. Corbel, J. P. Kamerling, and J. F. Vliegenthart. 2002. Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197. Infect. Immun. 70:5107-5114.
18. 17a. Nencioni, L., G. Volpini, S. Peppoloni, M. Bugnoli, T. De Magistris, I. Marsili, and R. Rappuoli. 1991. Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment. Infect. Immun. 59:625-630.
19. Nussenzweig, R. S., and V. Nussenzweig. 1989. Antisporozoite vaccine for malaria: experimental basis and current status. Rev. Infect. Dis. Suppl. 3:S579-S585.
20. Plikaytis, B. D., P. F. Holder, and G. M. Carlone. 1996. User's manual 12, version 1.00. Centers for Disease Control and Prevention, Atlanta, Ga.
21. 19a. Porro, M., M. Saletti, L. Nencioni, L. Tagliaferri, and I. Marsili. 1980. Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Coiynebacterium diphtheriae and diphtheria toxoid. J. Infect. Dis. 142:716-724.
22. Pozsgay, V., C. Chu, L. Pannell, J. Wolfe, J. B. Robbins, and R. Schneerson. 1999. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopoiysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc. Natl. Acad. Sci. USA 96:5194-5197.
23. Ramirez, D. M., S. H. Leppla, R. Schneerson, and J. Shiloach. 2002. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J. Ind. Microbiol. Biotechnol. 28:232-238.
24. Schneerson, R., J. Kubler-Kielb, T. Y. Liu, Z. D. Dai, A. Yergey, P. Backlund, J. Shiloach, S. H. Leppla, F. Majadly, and J. B. Robbins. 2003. Poly-γ-D-glutamic acid protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc. Natl. Acad. Sci. USA 100:8945-8950.
25. Schneerson, R., O. Barrera, A. Sutton, and J. B. Robbins. 1980. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152:361-376.
26. Smego, R. A., B. Gebrian, and G. Desmangels. 1998. Cutaneous manifestations of anthrax in rural Haiti. Clin. Infect. Dis. 26:97-102.
27. Sterne, M. 1939. The use of anthrax vaccines prepared from avirulent (unencapsulated) variants of Bacillus anthracis. Onerstepoort J. Vet. Sci. Anim. Ind. 13:307-312.
28. Troy, F. A. 1973. Chemistry and biosynthesis of the poly(gamma-D- glutamyl) capsule in Bacillus licheniformis. II. Characterization and structural properties of the enzymatically synthesized polymer. J. Biol. Chem. 248:305-315.
29. Wang, T. T., P. F. Fellows, T. J. Leighton, and A. H. Lucas. 2004. Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate. FEMS Immunol. Med. Microbiol. 40:231-237.